Skip to main content
Equibles

FNY Investment Advisers, LLC

Position in OCEA — Ocean Biomedical, Inc.

CIK 1742998 NEW YORK, NY
Back to OCEA Full portfolio

Position in OCEA

as of Mar 31, 2026 · filed Apr 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
600
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCEA Over Time

Shares Held

Position Value (USD)

Derivatives in OCEA

reported options exposure · as of Sep 30, 2024
CallValue
$29
CallShares
30
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $19,945,542 across 57 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1
108,951 $13,455,448
2 ABVX
Abivax S.A.
 7,605 $1,013,442
3 SGMT
Sagimet Biosciences Inc.
 109,250 $844,502
4 APGE
Apogee Therapeutics, Inc.
 5,000 $663,650
5 JANX
Janux Therapeutics, Inc.
 30,850 $473,856
6 NKTR
Nektar Therapeutics
 5,500 $383,955
7 VERU
Veru Inc.
 105,081 $328,903
8 VKTX
Viking Therapeutics, Inc.
 8,170 $318,711

All Filings in OCEA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 — 600
2025-12-31 — 600
2025-09-30 — 600
2025-06-30 — 600
2025-03-31 $32 600
2024-12-31 $331 600
2024-09-30 $588 600
2024-09-30 $29 30
2024-06-30 $976 800
2024-06-30 $12 10
2024-06-30 $2 2
2024-03-31 $2 600